I am Rainer Gatz, from Copenhagen in Denmark.

Well, based on the findings from last year's studies and the current body of evidence, my main takeaway is that we should exercise caution when using colloids—particularly in septic patients. The potential risks may outweigh the benefits, and until we have more definitive data, it's wise to take a conservative approach.

There are ongoing trials, especially those evaluating the role of albumin in critical care, and their results will be crucial in guiding future practice. So for now, it's best to hold off on routine colloid use in sepsis and wait for the evidence to catch up.